Demant A/S Total Liabilities
Demant A/S total liabilities. Based on the latest financial reports, Demant A/S (DEMANT) has total liabilities worth Dkr29.16 Billion DKK (≈ $4.56 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check DEMANT financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Demant A/S (2002–2025)
Total liabilities of Demant A/S from 2002 to 2025. This chart illustrates how Demant A/S's total liabilities have evolved over time, based on quarterly financial data. Explore Demant A/S strategic investment ratio to see how much of total assets are deployed in long-term investments.
Demant A/S Competitors by Total Liabilities
The table below lists competitors of Demant A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Erie Indemnity Company
NASDAQ:ERIE
|
USA | $1.09 Billion |
|
Huaneng Power International Inc
SHG:600011
|
China | CN¥380.25 Billion |
|
BUREAU VERITAS ADR EO-12
F:4BV0
|
Germany | €5.29 Billion |
|
Mueller Industries Inc
NYSE:MLI
|
USA | $683.25 Million |
|
Renaissancere Holdings Ltd
NYSE:RNR
|
USA | $35.16 Billion |
|
Cipla Limited
NSE:CIPLA
|
India | Rs71.39 Billion |
|
JD HEALTH INTL LTD
F:8ZN
|
Germany | €22.72 Billion |
|
Nextpower Inc.
NASDAQ:NXT
|
USA | $1.71 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Demant A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Demant A/S balance sheet assets.
Liquidity & Leverage Metrics
Demant A/S Total Liabilities Ratios Explained
Demant A/S total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.96 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.75 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Demant A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Demant A/S (2002–2025)
The table below shows the annual total liabilities of Demant A/S from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Dkr29.16 Billion ≈ $4.56 Billion |
+27.84% |
| 2024-12-31 | Dkr22.81 Billion ≈ $3.57 Billion |
+7.53% |
| 2023-12-31 | Dkr21.21 Billion ≈ $3.32 Billion |
-0.41% |
| 2022-12-31 | Dkr21.30 Billion ≈ $3.33 Billion |
+26.16% |
| 2021-12-31 | Dkr16.88 Billion ≈ $2.64 Billion |
+23.67% |
| 2020-12-31 | Dkr13.65 Billion ≈ $2.14 Billion |
-3.57% |
| 2019-12-31 | Dkr14.15 Billion ≈ $2.21 Billion |
+30.13% |
| 2018-12-31 | Dkr10.88 Billion ≈ $1.70 Billion |
+23.75% |
| 2017-12-31 | Dkr8.79 Billion ≈ $1.38 Billion |
+2.41% |
| 2016-12-31 | Dkr8.58 Billion ≈ $1.34 Billion |
+8.77% |
| 2015-12-31 | Dkr7.89 Billion ≈ $1.23 Billion |
+40.02% |
| 2014-12-31 | Dkr5.63 Billion ≈ $881.64 Million |
+6.78% |
| 2013-12-31 | Dkr5.28 Billion ≈ $825.63 Million |
+11.85% |
| 2012-12-31 | Dkr4.72 Billion ≈ $738.17 Million |
+8.66% |
| 2011-12-31 | Dkr4.34 Billion ≈ $679.34 Million |
-0.01% |
| 2010-12-31 | Dkr4.34 Billion ≈ $679.43 Million |
+30.63% |
| 2009-12-31 | Dkr3.32 Billion ≈ $520.11 Million |
-1.82% |
| 2008-12-31 | Dkr3.39 Billion ≈ $529.73 Million |
+2.88% |
| 2007-12-31 | Dkr3.29 Billion ≈ $514.90 Million |
+33.58% |
| 2006-12-31 | Dkr2.46 Billion ≈ $385.46 Million |
+15.29% |
| 2005-12-31 | Dkr2.14 Billion ≈ $334.34 Million |
+19.02% |
| 2004-12-31 | Dkr1.80 Billion ≈ $280.90 Million |
+20.27% |
| 2003-12-31 | Dkr1.49 Billion ≈ $233.56 Million |
-4.54% |
| 2002-12-31 | Dkr1.56 Billion ≈ $244.67 Million |
-- |
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Hol… Read more